🔗 Share this article

Chancellor Reeves has stated she is preparing "focused measures to address cost of living issues" in the forthcoming Budget.

During an interview with media outlets, she noted that reducing price rises is a shared task of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 advanced economies this calendar year and the following year.

Potential Energy Bill Measures

It is understood the government could take action to bring down energy bills, for example by slashing the present 5% rate of value-added tax applied on energy.

An additional possibility is to cut some of the regulatory levies presently added to bills.

Budgetary Constraints and Expert Predictions

The government will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much room there is for these actions.

The view from the majority of economists is that Reeves will have to introduce tax rises or expenditure reductions in order to fulfill her self-imposed debt limits.

Earlier on Thursday, calculations showed there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of expectations.

"It is a collective task between the Bank of England and the government to bear down further on some of the drivers of inflation," the Chancellor stated to reporters in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Pledges and International Concerns

While much of the attention has been on likely tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her vow to campaign commitments not to increase rates on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with rising geopolitical and trade issues for the fiscal revenue measures, probably to be focused on those "most able to pay."

International Economic Tensions

Referring to worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests invariably come first."

Recent announcement by China to strengthen export controls on critical minerals and other materials that are crucial for advanced tech production led US President the US President to suggest an extra 100% tariff on imports from China, increasing the risk of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary described the Chinese move "economic coercion" and "a global supply chain power grab."

Inquired about considering the US offer to join its conflict with China, Reeves said she was "extremely troubled" by China's measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "bad for the international commerce and creates further challenges."

"In my view there are fields where we must address China, but there are also important chances to sell into Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that balance correct."

The chancellor also confirmed she was cooperating with other major economies "regarding our own essential resources approach, so that we are less reliant."

NHS Medicine Costs and Funding

Reeves also admitted that the cost the NHS pays for medicines could rise as a consequence of current talks with the US government and its drugs companies, in exchange for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or abandoning projects in the United Kingdom, with some attributing the insufficient payments they are obtaining.

Recently, the government science advisor said the cost the NHS pays for drugs would have to go up to prevent firms and drug research funding departing from the United Kingdom.

Reeves stated to media: "We have seen because of the payment system, that clinical trials, new drugs have not been provided in the UK in the manner that they are in other European countries."

"The objective is to ensure that individuals receiving treatment from the NHS are able to access the top critical drugs in the world. And so we are looking at all of that, and... aiming to secure increased investment into Britain."